Helga Rübsamen-Schaeff

Former Senior Vice President & Global Head, Anti Infective Research at Bayer HealthCare AG

Helga Rübsamen-Schaeff

Helga Rübsamen-Schaeff

Former Senior Vice President & Global Head, Anti Infective Research at Bayer HealthCare AG

Overview
Career Highlights

Chemotherapeutic Research Institute Georg-Speyer-Haus

RelSci Relationships

373

Number of Boards

4

Birthday

01/1949

Age

69

Relationships

Chairman, Works Council Merck Darmstadt & Gernsheim at Merck KGaA

Managing Partner at Bondi Immobilien-Consulting GmbH

Chief Executive Officer at M+W Group GmbH

Commercial Director & Co-Owner at Weingut Castel Peter

Former Chief Executive Officer at Biotest AG

Managing Director at Altmann-Analytik GmbH & Co. KG

Former Chief Financial Officer at Bayer AG

Industrial Partner for Healthcare & Pharma at Rantum Capital Management GmbH

Chief Financial Officer at Merck KGaA

Chief Operating Officer at Merck KGaA

Subscribe to RelSci Professional to see 373 more Relationships
Paths to Helga Rübsamen-Schaeff
Potential Connections via
Relationship Science
You
Helga Rübsamen-Schaeff
Former Senior Vice President & Global Head, Anti Infective Research at Bayer HealthCare AG
Education
Doctorate Degree

University of Münster has one of the oldest leading business schools in Germany (Münster School of Business and Economics). It's one of the few German AACSB accredited Business Schools. Great store is set by the international accreditation of the degree courses and further education programs. All the programs offer outstanding teaching quality. The aim is to be a major breeding ground for those who are destined to achieve eminence in academia or the world of management. A high value is placed on close contacts with the practicalities of business life and economic policy as well as on the early integration of current research into the teaching and learning environment. We seek to encourage the transfer of knowledge between tertiary educational institutions and the realm of practical realities. Despite high student numbers, the School manages to offer accompanying classes and seminars for small groups, thereby promoting mutual exchange and academic discussion.

Career History
Managing Director
2006 - 2015

AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany.

Senior Vice President & Global Head, Anti Infective Research
2001 - 2006

Bayer HealthCare AG provides healthcare, agriculture, plastics and chemical products. It is an independent company comprising five divisions: Animal Health, Consumer Care, Diabetes Care, Diagnostics and Pharmaceuticals. The company covers the fields of animal health, genetically produced medicines, over the counter products, diagnostic products and prescription drugs. The company is headquartered in Leverkusen, Germany.

Director, Antiviral Research
1993 - 2006

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal year 2012, Bayer employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.

Subscribe now for extended career history
Boards & Committees
Member, Supervisory Board
2015 - Current

4SC AG engages in the development of small molecule drugs that targets cancer through epigenetic mechanisms. It also involves in the preclinical and clinical development of its products. Its assets are resminostat, 4SC-202, and 4SC-208. The company was founded by Ulrich Dauer, Daniel Vitt, Stefan Busemann, and Klaus-Peter Gulden in 1997 and is headquartered in Planegg-Martinsried, Germany.

Member, Supervisory Board
2014 - Current

Merck KGaA engages in the manufacturing of pharmaceutical and chemical products. It operates through the following segments: Healthcare, Life Science, and Performance Materials. The Healthcare segment comprises the businesses with prescription and over-the-counter pharmaceuticals and biopharmaceuticals as well as allergy products. The Life Science segment offers solutions to research and analytical laboratories in the pharmaceutical/biotechnology industry or in academic institutions, and customers manufacturing large- and small-molecule drugs. The Performance Materials segment includes specialty chemicals, which are used in a variety of end products. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Member, Board of Partners
2014 - Current

E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany.

Subscribe now to see 1 more corporate board memberships
Subscribe now to see non-profit board memberships for over 7 million people
Subscribe now to see government board memberships for over 7 million people
Investments
Details Hidden

AiCuris GmbH & Co. KG provides research and development services for antiviral and antibacterial agents. The firm develops drugs against viruses such as human cytomegalovirus, herpes simplex virus, hepatitis B virus and human immunodeficiency virus. The company was founded in March 2006 and is headquartered in Wuppertal, Germany.

Subscribe now to see investments for over 7 million people